Press enter after choosing selection

Dr. James French & Albert Ryder Examine A Chemical Model Of Vira-A In A Parke Davis Laboratory, January 1979 Photographer: Cecil Lockard

Dr. James French & Albert Ryder Examine A Chemical Model Of Vira-A In A Parke Davis Laboratory, January 1979 image
Year:
1979
Published In:
Ann Arbor News, January 2, 1979
Caption:
Dr. James French (right) of Ann Arbor, who synthesized the first drug effective against death-dealing herpes encephalitis at the local Parke-Davis laboratories, shows a chemistry model of the drug to Albert Ryder of Detroit, the firm's research planning administrator. Ryder, an organic chemist, made it all possible by isolating the virus-killing substance from soil samples. (News photo by Cecil Lockard)

Dr. Robert F. Korns, Dr. Thomas Francis, Jr. and Robert B. Voight during briefing session for newsmen concerning polio vaccine evaluation study, April 1955

Dr. Robert F. Korns, Dr. Thomas Francis, Jr. and Robert B. Voight during briefing session for newsmen concerning polio vaccine evaluation study, April 1955 image
Year:
1955
Published In:
Ann Arbor News, April 4, 1955
Caption:
Lead Salk Vaccine Research: Dr. Robert F. Korns (left), Dr. Thomas Francis, Jr. (center), and Robert B. Voight are shown here during Saturday briefing session for newsmen concerning the procedures of the polio vaccine evaluation study at the University. Dr. Francis directs the study, Dr. Korns is deputy director and Voight is chief statistician.

Dr. Thomas Francis, with file drawers containing statistical medical information, April 1955

Dr. Thomas Francis, with file drawers containing statistical medical information, April 1955 image
Year:
1955
Published In:
Ann Arbor News, April 4, 1955
Caption:
A Long, Sometimes Wearisome Job: Dr. Thomas Francis, Jr., leans somewhat wearily on one of the file drawers containing statistical medical information on the nearly 2,000,000 children involved in the Salk polio evaluation study, which Dr. Francis heads. The files are kept in the University's old Maternity Hospital. Two children of Dr. Jonas Salk of Pittsburgh, originator of the vaccine, were born in the Maternity Hospital where the study is now being carried on.